by D Bishev Cited by 18The most commonly observed adverse side effects were atrial The side effect profile was limited for the majority of individuals taking mavacamten.
Mavacamten - Produced by Bristol Meyers Squibb under the tradename Camzyos. There is interest in future trials in the non-obstructed population. SIDE EFFECTS
reduction. Mavacamten showed greater reduction in NYHA, larger effects on increase of pVO 2, and sig-nificant reduction of the LVOT gradient. Mavacamten was also found to be well tolerated, like the placebo. The side effect profile was limited for the majority of individuals taking mavacamten. In the future, authors
The side effect profile was limited for the majority of individuals taking mavacamten. In the future, authors recommended dose-optimisation studies, and studies
The most common side-effects were dizziness and headache. Mavacamten costs 1073. days treatment at the list price, but the company has agreed to make it available to NHS patients at a confidential discount. Mavacamten will be available to eligible patients for NHS use in England and Wales over the coming months.
Interactions; Side-effects; Conception and contraception Scottish Medicines Consortium (SMC) decisions For mavacamten. SMC No. SMC2618. Mavacamten (Camzyos
side effects remain an important unmet need in the treatment of this disease. Mavacamten, a recently approved cardiac myosin inhibitor
Mavacamten is used to treat the obstructive form These medications may help improve symptoms and function, but may have side effects.
Mavacamten may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: dizziness; fainting; Some side effects can be serious. If you experience any of those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment. Mavacamten may cause other side effects.
Comments
one of my own pet peeves, sorry